test

Harold Schaaff

@Soleus Capital Management, L.p.

Latest period2024 - Q3ReportedManaged Assets$1.291BTotal holdings87
Assets growth rate13.9%Assets growth rate (2-Q avg)-0.97%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Soleus Capital Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 87 positions.

Assets under management

The assets under management (AUM) of Soleus Capital Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.291B in assets, with a quarterly growth rate of 13.9% and a 2-quarter average growth rate of -0.97%. The portfolio is managed by Harold Schaaff, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ELVElevance Health Inc
Recent Activity
New Position
1.2%
$15.418M
29,650 shares@ $520.0 avg price
RIGLRigel Pharmaceuticals Inc
Recent Activity
Decreased -10.43%
1.18%
$15.125M
934,788 shares@ $16.19 avg price
PRAXPraxis Precision Medicines I
Recent Activity
Decreased -51.33%
1.16%
$14.926M
259,398 shares@ $57.55 avg price
KROSKeros Therapeutics Inc
Recent Activity
Increased 1.36%
1.01%
$13.043M
224,600 shares@ $58.07 avg price
CGONCg Oncology Inc
Recent Activity
Decreased -19.78%
1%
$12.85M
340,585 shares@ $37.73 avg price
IMUXImmunic Inc
Recent Activity
0.94%
$12.033M
7.293M shares@ $1.66 avg price
BHCBausch Health Cos Inc
Recent Activity
Increased 18.08%
0.9%
$11.62M
1.424M shares@ $8.16 avg price
PHVSPharvaris N V
Recent Activity
Increased 49.76%
0.86%
$11.078M
598,169 shares@ $18.53 avg price
LBPHLongboard Pharmaceuticals In
Recent Activity
New Position
0.83%
$10.608M
318,269 shares@ $33.34 avg price
OFIXOrthofix Med Inc
Recent Activity
Increased 1090.07%
0.74%
$9.48M
606,933 shares@ $15.62 avg price